Harrow, Inc. financial data

Symbol
HROW, HROWL, HROWM on Nasdaq
Industry
Pharmaceutical Preparations
Location
102 Woodmont Blvd, Suite 610, Nashville, TN
State of incorporation
DE
Fiscal year end
December 31
Former names
HARROW HEALTH, INC. (to 9/20/2023), Imprimis Pharmaceuticals, Inc. (to 12/17/2018), TRANSDEL PHARMACEUTICALS INC (to 2/27/2012), Bywater Resources, Inc (to 9/12/2007)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 230 % -47%
Quick Ratio 17.2 % -59.2%
Debt-to-equity 411 % -17.8%
Return On Equity -54.2 % -39.5%
Return On Assets -10.6 % -64.3%
Operating Margin -5.29 % -271%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 35.6M shares +1.42%
Common Stock, Shares, Outstanding 35.6M shares +1.41%
Entity Public Float 464M USD +192%
Common Stock, Value, Issued 35K USD 0%
Weighted Average Number of Shares Outstanding, Basic 35.7M shares +4.22%
Weighted Average Number of Shares Outstanding, Diluted 35.7M shares +4.22%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 169M USD +48.2%
Research and Development Expense 10.8M USD +169%
Operating Income (Loss) -8.95M USD -354%
Nonoperating Income (Expense) -24.3M USD -47.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -33.3M USD -156%
Income Tax Expense (Benefit) 20K USD -98.7%
Net Income (Loss) Attributable to Parent -33.4M USD -135%
Earnings Per Share, Basic -0.94 USD/shares -114%
Earnings Per Share, Diluted -0.94 USD/shares -114%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 72.6M USD +10.7%
Accounts Receivable, after Allowance for Credit Loss, Current 53.7M USD +191%
Inventory, Net 10.2M USD +13.8%
Other Assets, Current 1.45M USD +1129%
Assets, Current 147M USD +33.4%
Property, Plant and Equipment, Net 3.63M USD -0.11%
Operating Lease, Right-of-Use Asset 9.38M USD +34.5%
Intangible Assets, Net (Excluding Goodwill) 189M USD +16.3%
Goodwill 332K USD 0%
Assets 352M USD +22.9%
Employee-related Liabilities, Current 7.19M USD +35.1%
Accrued Liabilities, Current 59K USD
Contract with Customer, Liability, Current 137K USD -10.5%
Liabilities, Current 95M USD +399%
Operating Lease, Liability, Noncurrent 9.5M USD +41.1%
Liabilities 294M USD +39.5%
Retained Earnings (Accumulated Deficit) -158M USD -26.8%
Stockholders' Equity Attributable to Parent 58M USD -23.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 57.6M USD -23.6%
Liabilities and Equity 352M USD +22.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.63M USD +43.7%
Net Cash Provided by (Used in) Financing Activities -809K USD -101%
Net Cash Provided by (Used in) Investing Activities -110K USD +99.9%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 35.6M shares +1.41%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.55M USD +92.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 72.6M USD +10.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.34M USD +58.4%
Deferred Tax Assets, Valuation Allowance 15.6M USD -8.17%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 10M USD +33.1%
Depreciation 351K USD +21%
Payments to Acquire Property, Plant, and Equipment 92K USD -81.5%
Lessee, Operating Lease, Liability, to be Paid 14.4M USD +36.4%
Property, Plant and Equipment, Gross 14.6M USD +9.02%
Operating Lease, Liability, Current 507K USD -35.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.77M USD +61.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.39M USD +9.83%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +15.2%
Deferred Income Tax Expense (Benefit) -288K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.43M USD +44.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.64M USD +47.3%
Deferred Tax Assets, Operating Loss Carryforwards 4.67M USD -50.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.34M USD +38.1%
Operating Lease, Payments 1.29M USD +5.31%
Additional Paid in Capital 216M USD +7.79%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 10.2M USD +26.8%
Deferred Tax Assets, Net of Valuation Allowance 15.6M USD -8.17%
Share-based Payment Arrangement, Expense 17M USD +25.4%
Interest Expense 22M USD +116%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%